Clinical Research Informer

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

FEBRUARY 7, 2024

Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S. They held roundtable conversations with experts to understand their thoughts on what the FDA might do to better communicate, and they conducted polls and held 25 individual interviews. Speaker Susan C.

Regulation

Regulation Production Clinical Trials Clinical Trials

Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

Roots Analysis

MARCH 8, 2023

It is worth noting that smart labels contain a transponder code which can be read by sophisticated devices, including radio frequency identification device (RFID) tags and near-field communication (NFC) chips. While most smartphones can read NFC chips, RFID tags can only be read by specialized receivers.

Medicine

Medicine Production Manufacturing Containment

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Rethinking Clinical Trials

JULY 13, 2023

The daily workflow consisted of a daily electronic health record (EHR) query that identified patients who had heart failure with reduced ejection fraction, who were admitted for any cause within sites in the healthcare system. The recommendations were communicated in the EHR as a note and the primary team received a page notification.

Clinical Trials

Clinical Trials Clinical Trials Scientist Research

Grand Rounds November 17, 2023: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: Results from the Nudge Study (Michael Ho, MD, PhD; Sheana Bull, PhD)

Rethinking Clinical Trials

NOVEMBER 21, 2023

The second aim was to conduct a pilot intervention to demonstrate feasibility of delivering the intervention and preliminary effects in a 3 healthcare systems. The idea was to engage the patient, providers, and healthcare system leaders to design, refine, and implement the pilot. The study would then recalculate the gaps.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

BD partners with Biocorp on connected self-injection devices

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Drug Delivery

Drug Delivery Manufacturing Drugs Marketing

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

Rethinking Clinical Trials

SEPTEMBER 22, 2022

The Danish Nationwide Registries include the Danish Patient Registry (a registry of every inpatient and outpatient contact in the Danish free-for-all public healthcare system); the Danish Medicines Registry (a registry of every filed prescription at any pharmacy in Denmark including information on pill strength, pack size, etc.); Key Points.

Trials

Trials Cardiology Vaccination Vaccine

What can pharma marketing learn from other regulated industries?

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Joanna Carlish. Personalising marketing content.

Regulation

Regulation Marketing Sales Branding

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

XTalks

FEBRUARY 8, 2024

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.

Life Science

Life Science Marketing Branding Drugs

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

APRIL 11, 2024

Commercial : Improved experience and communication between patients and doctors. In the pharma industry, precision engagement can be used to present patients, healthcare professionals (HCPs), and other stakeholders with relevant information and support at the right time. It uses customer insights to deliver personalized experiences.

Compliance

Compliance Marketing Drugs Pharma Companies

No sign of stopping: The rise of cell and gene therapy

Drug Discovery World

MAY 22, 2023

Ryan Leahy , a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. But are these price tags a barrier to access? million per dose.

Gene Therapy

Gene Therapy Gene Drugs Contamination

Ways IoT Has Transformed The Pulse Of Healthcare, And Will Continue To Do So In The Future

Delveinsight

JULY 22, 2020

The technology over the past few years has opened many new avenues and possibilities that have radically transformed the healthcare industry’s outlook. Today the tech-based healthcare industry is providing many unique solutions to the patient’s care which are more efficient and effective than the traditional services.

Doctors

Doctors Doctor Marketing Production

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

SEPTEMBER 15, 2020

The huge rise in the use of telemedicine services during lockdown has brought care directly to patients in their homes, while pharma’s communications with healthcare professionals (HCPs) has experienced a similar push to digital channels. Jeremy Richter, Tag. We’re all trying to find ways to automate.

Branding

Branding Marketing Pharma Companies Life Science

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. —- End —-.

Clinical Trials

Clinical Trials Clinical Trials Vaccination Vaccine

RFID: The future of smart labelling?

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production

Production Pharma Production Pharma Companies Drugs

Patient adherence – the key to restoring trust in pharma

pharmaphorum

JANUARY 31, 2023

Even when medical providers communicate this information to patients, it can be confusing or overwhelming, often leaving people feeling like they’ve been left in the dark. This ultimately impacts patient perception of healthcare services in general. He is the founder of several digital health start-ups.

Clinical Trials

Clinical Trials Clinical Trials Trials Vaccination

NICE ‘no’ to Roche’s risdiplam for SMA not unexpected, says patient group

pharmaphorum

JUNE 2, 2021

Evrysdi was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 20 May, almost two months after the drug go the go-ahead in the EU. million price tag make it is the most expensive treatment ever approved for NHS funding, as it provides “exceptional benefit” to babies with the disease.

Gene Therapy

Gene Therapy Gene Drugs Medicine

Biogen’s Aducanumab Becomes First Drug Approved for Alzheimer’s in Nearly 20 Years Despite Controversy

XTalks

JUNE 9, 2021

The historic and highly anticipated approval created a flurry of excitement in the Alzheimer’s disease space for patients, healthcare practitioners, advocacy groups and Biogen shareholders alike, as shares of the company jumped more than 50 percent after the announcement. Aducanumab Controversy and Price Tag.

Drugs

Drugs Clinical Trials Clinical Trials Trials

New to ELRIG Drug Discovery 2022: Tech Theatre supported by DDW

Drug Discovery World

OCTOBER 3, 2022

He has over 12 years of experience in the healthcare sector and is the author of over 30 peer- reviewed scientific articles. Patey spends much of his time working with lab suppliers to communicate their product sustainability to lab users and to reduce the environmental impact of the lab supply chain.

Drugs

Drugs Scientist Bioinformatics Medicine

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. It can be used for sales, marketing and patient communication materials, in print or digital form. A modular content ecosystem.

Marketing

Marketing Branding Sales Life Science

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

NOVEMBER 19, 2021

Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. But Claire Gillis, CEO at VMLY&Rx, a member of WPP, says the semantics between marketing and comms can be debated but vaccine adoption is always a communications challenge. Moving forward, Gillis says communications will continue to be vital.

Sales

Sales Vaccination Vaccine Marketing

A history of Johnson & Johnson

pharmaphorum

FEBRUARY 26, 2021

United under the common name of J&J, Janssen is now split into three different businesses – Janssen Research & Development, Janssen Healthcare Innovation and Janssen Diagnostics. In 2006, J&J acquired Pfizer Consumer Healthcare for $16.6 Litigation & controversy. billion in cash.

Sales

Sales Production Pharma Companies Marketing

Pharma By The Numbers: A Retrospective Look at the Industry and 20 Years of Xtalks History

XTalks

MARCH 22, 2023

No matter how you’re looking to communicate your expertise in the life sciences, your audience is already here, so contact us to become an Xtalks partner. And make sure you’re registered for our free online community for instant access to thousands of on-demand webinars.

Life Science

Life Science Drugs FDA Approval Vaccination

Salesforce Platform Capabilities

Cloudbyz

JUNE 1, 2023

Collaboration Salesforce offers a robust suite of collaboration features that enable users to communicate, share ideas, manage projects, and work together more effectively. Employee Communities: Employee communities enable internal collaboration and communication.

Compliance

Compliance Development Branding Production

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.

Marketing

Marketing Drugs Research Analyst Manufacturing

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Drugs

Drugs Manufacturing Hormones Contract Manufacturing

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Drugs

Drugs Manufacturing Hormones Contract Manufacturing

Clinical Research Informer

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

Trending Sources

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Grand Rounds November 17, 2023: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: Results from the Nudge Study (Michael Ho, MD, PhD; Sheana Bull, PhD)

BD partners with Biocorp on connected self-injection devices

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

What can pharma marketing learn from other regulated industries?

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

AI-Powered Precision Engagement in Commercial and Medical Functions

No sign of stopping: The rise of cell and gene therapy

Ways IoT Has Transformed The Pulse Of Healthcare, And Will Continue To Do So In The Future

3 ways pharma marketers can draw inspiration from digitally-native brands

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

RFID: The future of smart labelling?

Patient adherence – the key to restoring trust in pharma

NICE ‘no’ to Roche’s risdiplam for SMA not unexpected, says patient group

Biogen’s Aducanumab Becomes First Drug Approved for Alzheimer’s in Nearly 20 Years Despite Controversy

New to ELRIG Drug Discovery 2022: Tech Theatre supported by DDW

What is modular content and why do pharma marketers need it NOW?

The Covid cash cow – a look at the Covid vaccine sales figures

A history of Johnson & Johnson

Pharma By The Numbers: A Retrospective Look at the Industry and 20 Years of Xtalks History

Salesforce Platform Capabilities

Risk sharing agreements soar as market access risk increases

The “Medical Bypass”: new drugs to strike obesity

The “Medical Bypass”: new drugs to strike obesity

Stay Connected